The fight against malaria continues to advance in Southeast Asia and Sub-Saharan Africa, led by the...
Novartis researchers have discovered a compound that is showing promise against three parasites that...
Combination of two compounds shows promise in the lab
Joe Jimenez, Novartis CEO and President of the European Federation of Pharmaceutical Industries and Associations discusses the critical importance of protecting Intellectual Property.
Novartis focuses its business on three divisions with innovation power and global scale: innovative medicines, eye care and generics.
This site is intended for a global audience.